INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $235,523 | +125.4% | 461,811 | +71.9% | 0.00% | – |
Q3 2023 | $104,504 | -92.7% | 268,650 | -91.6% | 0.00% | – |
Q2 2023 | $1,427,050 | +86.3% | 3,196,081 | +242.1% | 0.00% | – |
Q1 2023 | $765,978 | +58.6% | 934,120 | +201.7% | 0.00% | – |
Q4 2022 | $482,978 | +600.0% | 309,601 | +676.3% | 0.00% | – |
Q3 2022 | $69,000 | -72.0% | 39,881 | -72.0% | 0.00% | – |
Q2 2022 | $246,000 | -87.3% | 142,436 | -73.5% | 0.00% | – |
Q1 2022 | $1,930,000 | -47.9% | 537,503 | -27.5% | 0.00% | -100.0% |
Q4 2021 | $3,701,000 | -29.7% | 741,743 | +0.8% | 0.00% | 0.0% |
Q3 2021 | $5,266,000 | -28.8% | 735,600 | -7.8% | 0.00% | -66.7% |
Q2 2021 | $7,395,000 | -44.3% | 797,731 | -44.2% | 0.00% | -50.0% |
Q1 2021 | $13,265,000 | -13.8% | 1,429,439 | -17.8% | 0.01% | -25.0% |
Q4 2020 | $15,387,000 | -67.6% | 1,738,682 | -57.5% | 0.01% | -72.4% |
Q3 2020 | $47,454,000 | -71.3% | 4,090,927 | -33.3% | 0.03% | -76.8% |
Q2 2020 | $165,340,000 | +1388.6% | 6,135,038 | +311.0% | 0.12% | +1036.4% |
Q1 2020 | $11,107,000 | +18108.2% | 1,492,877 | +4911.2% | 0.01% | – |
Q3 2019 | $61,000 | -77.8% | 29,791 | -68.2% | 0.00% | – |
Q2 2019 | $275,000 | +316.7% | 93,656 | +692.9% | 0.00% | – |
Q3 2018 | $66,000 | -10.8% | 11,812 | -24.9% | 0.00% | – |
Q1 2018 | $74,000 | +21.3% | 15,722 | +6.6% | 0.00% | – |
Q4 2017 | $61,000 | -7.6% | 14,750 | +41.8% | 0.00% | – |
Q3 2017 | $66,000 | -38.9% | 10,400 | -24.6% | 0.00% | – |
Q2 2017 | $108,000 | -61.4% | 13,800 | -54.4% | 0.00% | -100.0% |
Q2 2016 | $280,000 | +105.9% | 30,254 | +93.3% | 0.00% | +100.0% |
Q1 2016 | $136,000 | +2.3% | 15,653 | -31.9% | 0.00% | 0.0% |
Q3 2015 | $133,000 | -23.1% | 22,983 | +8.6% | 0.00% | 0.0% |
Q2 2015 | $173,000 | -79.5% | 21,169 | -72.8% | 0.00% | -90.9% |
Q2 2014 | $843,000 | – | 77,953 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|